Extracellular matrix metalloproteinase inducer is increased in smokers' bronchoalveolar lavage fluid

Tomoko Betsuyaku, Mishie Tanino, Katsura Nagai, Yasuyuki Nasuhara, Masaharu Nishimura, Robert M. Senior

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Extracellular matrix metalloproteinase inducer (EMMPRIN), also called basigin, is present in the lung during development, but its expression in normal adult lung is minimal. Increases of EMMPRIN have been found in various forms of experimental lung injury. To determine whether EMMPRIN might be involved in alveolar injury/repair associated with smoking, we developed an ELISA for EMMPRIN and applied it to bronchoalveolar lavage fluids from never-smokers (n = 7), former smokers (n = 16), and current smokers (n = 58). The smoker groups included subjects with emphysema, as determined by high-resolution chest computed tomography. EMMPRIN levels were significantly elevated in current and former smokers (315 ± 20 and 175 ± 15 pg/ml SEM, respectively, compared with 31 ± 7 pg/ml in never-smokers), but the EMMPRIN levels of smokers with emphysema were not different from smokers without emphysema. Immunohistochemistry of smokers' lung tissue showed EMMPRIN in bronchiolar epithelium and alveolar macrophages, but EMMPRIN mRNA in alveolar macrophages was not different between current and never-smokers. Matrix metalloproteinase-1 was also detectable in the bronchoalveolar lavage fluid from some smokers but not in never-smokers. These findings indicate that smoking is associated with increased intrapulmonary EMMPRIN. Whether EMMPRIN is involved in smoking-induced lung pathology remains to be determined.

Original languageEnglish
Pages (from-to)222-227
Number of pages6
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume168
Issue number2
DOIs
Publication statusPublished - 2003 Jul 15
Externally publishedYes

Fingerprint

CD147 Antigens
Bronchoalveolar Lavage Fluid
Emphysema
Lung
Smoking
Alveolar Macrophages
Matrix Metalloproteinase 1
Lung Injury

Keywords

  • Alveolar macrophages
  • Emphysema
  • Matrix metalloproteinases
  • Smoking

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Extracellular matrix metalloproteinase inducer is increased in smokers' bronchoalveolar lavage fluid. / Betsuyaku, Tomoko; Tanino, Mishie; Nagai, Katsura; Nasuhara, Yasuyuki; Nishimura, Masaharu; Senior, Robert M.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 168, No. 2, 15.07.2003, p. 222-227.

Research output: Contribution to journalArticle

Betsuyaku, Tomoko ; Tanino, Mishie ; Nagai, Katsura ; Nasuhara, Yasuyuki ; Nishimura, Masaharu ; Senior, Robert M. / Extracellular matrix metalloproteinase inducer is increased in smokers' bronchoalveolar lavage fluid. In: American Journal of Respiratory and Critical Care Medicine. 2003 ; Vol. 168, No. 2. pp. 222-227.
@article{9f4f17721f404d73ae286824841d3384,
title = "Extracellular matrix metalloproteinase inducer is increased in smokers' bronchoalveolar lavage fluid",
abstract = "Extracellular matrix metalloproteinase inducer (EMMPRIN), also called basigin, is present in the lung during development, but its expression in normal adult lung is minimal. Increases of EMMPRIN have been found in various forms of experimental lung injury. To determine whether EMMPRIN might be involved in alveolar injury/repair associated with smoking, we developed an ELISA for EMMPRIN and applied it to bronchoalveolar lavage fluids from never-smokers (n = 7), former smokers (n = 16), and current smokers (n = 58). The smoker groups included subjects with emphysema, as determined by high-resolution chest computed tomography. EMMPRIN levels were significantly elevated in current and former smokers (315 ± 20 and 175 ± 15 pg/ml SEM, respectively, compared with 31 ± 7 pg/ml in never-smokers), but the EMMPRIN levels of smokers with emphysema were not different from smokers without emphysema. Immunohistochemistry of smokers' lung tissue showed EMMPRIN in bronchiolar epithelium and alveolar macrophages, but EMMPRIN mRNA in alveolar macrophages was not different between current and never-smokers. Matrix metalloproteinase-1 was also detectable in the bronchoalveolar lavage fluid from some smokers but not in never-smokers. These findings indicate that smoking is associated with increased intrapulmonary EMMPRIN. Whether EMMPRIN is involved in smoking-induced lung pathology remains to be determined.",
keywords = "Alveolar macrophages, Emphysema, Matrix metalloproteinases, Smoking",
author = "Tomoko Betsuyaku and Mishie Tanino and Katsura Nagai and Yasuyuki Nasuhara and Masaharu Nishimura and Senior, {Robert M.}",
year = "2003",
month = "7",
day = "15",
doi = "10.1164/rccm.200301-103OC",
language = "English",
volume = "168",
pages = "222--227",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "2",

}

TY - JOUR

T1 - Extracellular matrix metalloproteinase inducer is increased in smokers' bronchoalveolar lavage fluid

AU - Betsuyaku, Tomoko

AU - Tanino, Mishie

AU - Nagai, Katsura

AU - Nasuhara, Yasuyuki

AU - Nishimura, Masaharu

AU - Senior, Robert M.

PY - 2003/7/15

Y1 - 2003/7/15

N2 - Extracellular matrix metalloproteinase inducer (EMMPRIN), also called basigin, is present in the lung during development, but its expression in normal adult lung is minimal. Increases of EMMPRIN have been found in various forms of experimental lung injury. To determine whether EMMPRIN might be involved in alveolar injury/repair associated with smoking, we developed an ELISA for EMMPRIN and applied it to bronchoalveolar lavage fluids from never-smokers (n = 7), former smokers (n = 16), and current smokers (n = 58). The smoker groups included subjects with emphysema, as determined by high-resolution chest computed tomography. EMMPRIN levels were significantly elevated in current and former smokers (315 ± 20 and 175 ± 15 pg/ml SEM, respectively, compared with 31 ± 7 pg/ml in never-smokers), but the EMMPRIN levels of smokers with emphysema were not different from smokers without emphysema. Immunohistochemistry of smokers' lung tissue showed EMMPRIN in bronchiolar epithelium and alveolar macrophages, but EMMPRIN mRNA in alveolar macrophages was not different between current and never-smokers. Matrix metalloproteinase-1 was also detectable in the bronchoalveolar lavage fluid from some smokers but not in never-smokers. These findings indicate that smoking is associated with increased intrapulmonary EMMPRIN. Whether EMMPRIN is involved in smoking-induced lung pathology remains to be determined.

AB - Extracellular matrix metalloproteinase inducer (EMMPRIN), also called basigin, is present in the lung during development, but its expression in normal adult lung is minimal. Increases of EMMPRIN have been found in various forms of experimental lung injury. To determine whether EMMPRIN might be involved in alveolar injury/repair associated with smoking, we developed an ELISA for EMMPRIN and applied it to bronchoalveolar lavage fluids from never-smokers (n = 7), former smokers (n = 16), and current smokers (n = 58). The smoker groups included subjects with emphysema, as determined by high-resolution chest computed tomography. EMMPRIN levels were significantly elevated in current and former smokers (315 ± 20 and 175 ± 15 pg/ml SEM, respectively, compared with 31 ± 7 pg/ml in never-smokers), but the EMMPRIN levels of smokers with emphysema were not different from smokers without emphysema. Immunohistochemistry of smokers' lung tissue showed EMMPRIN in bronchiolar epithelium and alveolar macrophages, but EMMPRIN mRNA in alveolar macrophages was not different between current and never-smokers. Matrix metalloproteinase-1 was also detectable in the bronchoalveolar lavage fluid from some smokers but not in never-smokers. These findings indicate that smoking is associated with increased intrapulmonary EMMPRIN. Whether EMMPRIN is involved in smoking-induced lung pathology remains to be determined.

KW - Alveolar macrophages

KW - Emphysema

KW - Matrix metalloproteinases

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=0042165852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042165852&partnerID=8YFLogxK

U2 - 10.1164/rccm.200301-103OC

DO - 10.1164/rccm.200301-103OC

M3 - Article

VL - 168

SP - 222

EP - 227

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 2

ER -